Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has led to growing concerns over increased transmissibility and the ability of some variants to partially escape immunity. Sera from participants immunized on a prime-boost schedule with the mRNA-1273 COVID-19 vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Angela, Koch, Matthew, Wu, Kai, Dixon, Groves, Oestreicher, Judy, Legault, Holly, Stewart-Jones, Guillaume B. E., Colpitts, Tonya, Pajon, Rolando, Bennett, Hamilton, Carfi, Andrea, Edwards, Darin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577347/
https://www.ncbi.nlm.nih.gov/pubmed/34549975
http://dx.doi.org/10.1128/JVI.01313-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577347/
https://www.ncbi.nlm.nih.gov/pubmed/34549975
http://dx.doi.org/10.1128/JVI.01313-21

Ejemplares similares